Maria Morozova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria Morozova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia D. Novokshonova
Institute of Ecology and Genetics of Microorganisms, Branch of the Perm Federal Research Center, Ural Branch of the Russian Academy of Sciences, 13 Goleva St., Perm 614081, Russia
1 shared publication - Mikhail Rayev
Institute of Ecology and Genetics of Microorganisms
1 shared publication - Pavel Khramtsov
Institute of Ecology and Genetics of Microorganisms
1 shared publication - Tatiana Bezukladnikova
Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Institute of Ecology and Genetics of Microorganisms, 614081 Perm, Russia
1 shared publication - Zarina Galaeva
Institute of Ecology and Genetics of Microorganisms
1 shared publication
Latest Publications
- Open Access
- 17 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A Systematic Investigation of TMB Substrate Composition for Signal Enhancement in ELISA
3,3',5,5'-Tetramethylbenzidine (TMB) remains one of the most widely utilized chromogenic substrates for horseradish peroxidase (HRP) in colorimetric immunoassays, including enzyme-linked immunosorbent assays (ELISA). Despite its introduction into ELISA workflows over four decades ago, limited research has been conducted to systematically optimize TMB substrate formulations. Recent advancements in the field have proposed innovative approaches to enhance HRP catalysis, such as the use of deep eutectic solvents and ionic liquids, alongside investigations into the chemical properties of TMB and its analogs to identify more efficient alternatives. However, the development of stable and high-performance TMB solutions for clinical diagnostics requires a comprehensive understanding of how formulation parameters influence signal intensity and stability. In this study, we address these gaps by conducting a systematic evaluation of key factors affecting TMB substrate performance, including buffer pH, composition and molarity, specific ion effects, incorporation of organic solvents, and the use of polymer stabilizers. Additionally, novel strategies for signal amplification, identified through an extensive review of literature and patents, were experimentally tested. Based on these findings, we developed an optimized TMB formulation that was benchmarked against existing formulations reported in the literature.
- 17 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA Systematic Investigation of TMB Substrate Composition for Signal Enhancement in ELISA
3,3',5,5'-Tetramethylbenzidine (TMB) remains one of the most widely utilized chromogenic substrates for horseradish peroxidase (HRP) in colorimetric immunoassays, including enzyme-linked immunosorbent assays (ELISA). Despite its introduction into ELISA workflows over four decades ago, limited research has been conducted to systematically optimize TMB substrate formulations. Recent advancements in the field have proposed innovative approaches to enhance HRP catalysis, such as the use of deep eutectic solvents and ionic liquids, alongside investigations into the chemical properties of TMB and its analogs to identify more efficient alternatives. However, the development of stable and high-performance TMB solutions for clinical diagnostics requires a comprehensive understanding of how formulation parameters influence signal intensity and stability. In this study, we address these gaps by conducting a systematic evaluation of key factors affecting TMB substrate performance, including buffer pH, composition and molarity, specific ion effects, incorporation of organic solvents, and the use of polymer stabilizers. Additionally, novel strategies for signal amplification, identified through an extensive review of literature and patents, were experimentally tested. Based on these findings, we developed an optimized TMB formulation that was benchmarked against existing formulations reported in the literature.